ETAO International Co. Lt... (ETAO)
1.91
-0.89 (-31.79%)
At close: May 08, 2024, 8:00 PM
Company Description
ETAO International Co., Ltd., a digital healthcare company, provides medical care and biomedical technologies to patients in China.
It is involved in designing an ecosystem that consist of hospitals, specialized clinics, artificial intelligence/big data diagnosis, medical analysis services, biotechnology companies, and an insurance agency company that enables patient to receive medical assistance and healthcare services.
The company is based in New York, New York.
ETAO International Co. Ltd.
| Country | United States |
| IPO Date | Jun 24, 2021 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 3,600 |
| CEO | Wensheng Liu |
Contact Details
Address: 1460 Broadway New York, New York United States | |
| Website | https://www.etao.world |
Stock Details
| Ticker Symbol | ETAO |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001939696 |
| CUSIP Number | n/a |
| ISIN Number | KYG313631072 |
| Employer ID | 00-0000000 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Tao Jin | Chief Executive Officer of ETAO China |
| Wensheng Liu | Chairman, Founder & Chief Executive Officer |
| Dr. Simon L. Tang Esq., Ph.D. | Vice Chairman & Chief Legal Officer |
| Wang Hui CPA | Interim Chief Financial Officer |
| Nakade Ryoshin | President of ETAO Japan |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 22, 2024 | 20-F/A | [Amend] Filing |
| May 06, 2024 | 6-K | Filing |
| May 01, 2024 | NT 20-F | Filing |
| May 01, 2024 | 6-K | Filing |
| Apr 11, 2024 | 20-F/A | [Amend] Filing |
| Mar 13, 2024 | 6-K | Filing |
| Mar 08, 2024 | 6-K | Filing |
| Feb 08, 2024 | 6-K | Filing |
| Jan 31, 2024 | 6-K | Filing |